Stefano Togni, Chief Commercial Officer – indena
5 October 2022
No Comments
Click HERE to download the PDF Indena is a full-service provider and partner for
Issue: Vol. 40
Christian Suà, CEO – Cerbios
5 October 2022
No Comments
Cerbios has over 40 years’ experience in the pharmaceutical industry and is specialized
Andrea Sentimenti, Marketing & Innovation Director – bormiolipharma
5 October 2022
No Comments
Drug therapeutical efficiency over time is a pivotal aspect to consider when producing
Steve Morrison, Regulatory Manager – Atlantia Clinical Trials
5 October 2022
No Comments
Atlantia Clinical Trials is a world class provider of human clinical studies, which
Environmental Risk Assessment of Medicinal Products: a complex issue
4 October 2022
No Comments
The great theme of the environmental risk assessment of medicinal products has been developed
CDMOs: Long on Tactical Supply Risk, Short on Strategic Planning for a Multipolar World Order – Pharma Outsourcing Best Practices Panel at CHEMSPEC Frankfurt, June 2022
4 October 2022
No Comments
INTRODUCTION Business needs long term stability in the global business environment but the last
Agile supply chain management and blockchain survey
4 October 2022
No Comments
While blockchain was originally designed for secure digital transactions, it has now gained traction in a variety of organizations as well where methodologies such as agile have been enabling true digital transformations.
This paper aims to explore whether blockchain and agile supply chains can contribute to healthcare and pharmaceutical innovation, as well to better understand future trends.
Consequently, we hope to provide strategic insights into major issues healthcare and pharmaceutical companies face, such as counterfeiting and anti-tampering measures, as well as a number of strategic options they are considering, such as agile supply chain management.
As a first step, we reviewed the available literature available to develop an initial theme understanding of the challenges, and the adopted strategies and connections between blockchain and innovation in supply chain management.
By analyzing network analysis results and understanding respondents’ relationships and connections, we can reveal how blockchain and agile supply chain management are interconnected.
CPHI Annual Report: Continuous Manufacturing Will Alter the Drug Manufacturing Landscape a Decade from Now
4 October 2022
No Comments
Ahead of CPhI, which is back in Frankfurt this year from Nov 1st – 3rd – with event numbers expected to meet or exceed pre-pandemic levels as pharma executive return en-masse – we spoke to CPhI Annual Report expert Bikash Chatterjee, CEO Pharmatech Associates on the increased use of continuous manufacturing for drugs, 10 years from now.
Sustainable, efficient manufacturing is driven by data – Key insights help you reduce the environmental footprint of your operations
4 October 2022
No Comments
The pharmaceutical sector is here to help people live healthier lives. But without a healthy planet, this action is compromised. Therefore, pharmaceutical manufacturers should act now to reduce their emissions and contribute to ambitious net zero targets. By adopting data-driven technologies that characterise Industry 4.0, such as Process Analytical Technology (PAT), companies can reduce the environmental impact of their processes and products. They can also futureproof their facilities, improving their profitability and competitiveness in an increasingly challenging and demanding marketplace.
Streamlining analytical method development with a focus on genotoxic impurities – Developing analytical methods for a range of genotoxic impurities
4 October 2022
No Comments
Development of chromatographic methods for the determination of genotoxic (GTI) or potential genotoxic (PGI) impurities can be time consuming and laborious. Having a generic approach to a method development strategy can aid in the generation of a suitable method in a shorter space of time. Several different approaches to method development are possible. This paper provides an overview of method development strategies to generate a suitable, reliable, robust, and even validatable method for the determination of genotoxic impurities. The discussion includes several examples of successfully developed and validated methods for a range of genotoxic impurities, including nitrosamines, by liquid chromatography (LC) and gas chromatography (GC).